Atrial fibrillation management is inadequate in India

Atrial Fibrillation (Afib) is a serious heart condition that affects many people worldwide but is often overlooked in India. Afib occurs when the heart's upper chambers beat too quickly or out of sync with the lower chambers. This can lead to symptoms like feelings of racing heart, shortness of breath, chest pain, and fatigue. However, some people may not notice any symptoms at all. The condition increases the risk of strokes, heart failure, and other serious health problems. It is more common in older adults and those with conditions like high blood pressure, diabetes, and obesity. Despite the risks, many cases of Afib remain undiagnosed, mainly because awareness and detection efforts are lacking. In Southeast Asia, including India, the prevalence of Afib is rising quickly. Studies show that the mortality rate from Afib is high, highlighting the need for better management strategies in the region. Experts stress that many people, including healthcare providers, still do not recognize Afib as a critical health issue. A recent study in Kerala showed that while many patients have risk factors for Afib, only a small percentage receive proper treatment to prevent strokes. Oral anticoagulants, which are key to managing Afib, are underused. The high costs of these medications and a lack of awareness about their benefits contribute to this issue. Experts believe that improving public knowledge about Afib, its symptoms, and the importance of seeking medical help is essential. New technologies, such as smartwatches that can detect Afib, may help with early diagnosis. A comprehensive care approach is recommended for managing Afib. This includes preventing strokes, effectively managing symptoms, and addressing other cardiovascular risks. Overall, there is an urgent need for greater awareness and better treatment practices to tackle Afib in India.